Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Inventory: 2022-2023

Historic Inventory for Amylyx Pharmaceuticals (AMLX) over the last 2 years, with Dec 2023 value amounting to $38.3 million.

  • Amylyx Pharmaceuticals' Inventory rose 292.29% to $38.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $38.3 million, marking a year-over-year increase of 292.29%. This contributed to the annual value of $38.3 million for FY2023, which is 292.29% up from last year.
  • Amylyx Pharmaceuticals' Inventory amounted to $38.3 million in FY2023, which was up 292.29% from $9.8 million recorded in FY2022.
  • In the past 5 years, Amylyx Pharmaceuticals' Inventory ranged from a high of $38.3 million in FY2023 and a low of $9.8 million during FY2022.
  • Moreover, its 2-year median value for Inventory was $24.0 million (2022), whereas its average is $24.0 million.
  • Data for Amylyx Pharmaceuticals' Inventory shows a peak YoY surged of 292.29% (in 2023) over the last 5 years.
  • Over the past 2 years, Amylyx Pharmaceuticals' Inventory (Yearly) stood at $9.8 million in 2022, then surged by 292.29% to $38.3 million in 2023.